BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  BD Completes Bard Acquisition, Creating New $16B Biotech Powerhouse

  The combined company is uniquely positioned to improve both the treatment of disease for patients and the process of care for health care providers.

  December 29, 2017

   · 

  7 min read
• Drug Development

  Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility

  This will be the site where the Company’s research arm, Cannevert Therapeutics will be conducting its first human study of CTL-X, a cannabis strain targeting pain management.

  December 29, 2017

   · 

  4 min read
• Scythian Announces No Material Change

  Scythian is also unaware of any material undisclosed change related to the Company that would explain the recent movements in the price of its common shares.

  December 29, 2017

   · 

  1 min read
• Business

  Atara Biotherapeutics to Host Corporate Update Conference Call on Friday, December 29, 2017, at 8:00 a.m. EST

  A replay of the webcast will be available on the Company’s website for 90 days following the live conference call.

  December 29, 2017

   · 

  4 min read
• Pharm Country

  Daxor Corporation Revises 2017 Dividend

  This dividend will be paid on Friday, January 12, 2018 to Daxor shareholders of record on Monday January 8, 2018.

  December 29, 2017

   · 

  1 min read
• Saniona Establish Equity Financing of Up to SEK 144M

  The financing is provided by Nice & Green, a private Swiss company, which specializes in financing solutions tailored to the requirements of listed growth companies within the biotech and cleantech industries.

  December 29, 2017

   · 

  8 min read
• Policy

  AVACEN Medical Announces Autism Clinical Trial

  Avacen Medical announced it will be using Crowdfunder.com to fund a double-blind, randomized, placebo-controlled clinical study in the first quarter of 2018 using the AVACEN 100 for autism behavior treatment.

  December 29, 2017

   · 

  4 min read
• Deals

  Thermo Fisher Scientific Completes Acquisition of Phenom-World

  Thermo Fisher will integrate the business into Thermo Fisher’s Analytical Instruments segment. Terms of the transaction were not disclosed.

  December 29, 2017

   · 

  1 min read
• Business

  Hebron Technology Co., Ltd. Reports Financial Results for the First Half of 2017

  Hebron Technology Co., Ltd. today announced its financial results for the six months ended June 30, 2017.

  December 29, 2017

   · 

  21 min read
• Business

  CEL-SCI Reports Fiscal 2017 Financial Results and Clinical & Corporate Developments

  CEL-SCI reported a net loss of ($14.36) million in fiscal year 2017 versus a net loss of ($11.51) million in fiscal 2016.

  December 29, 2017

   · 

  5 min read